Topics

Tisenc Medical Raises $12 Million for Point-of-Care Chemiluminescence Testing

23:24 EST 15 Jan 2020 | ChinaBio Today

Shenzhen Tisenc Medical Equipment, a China point-of-care testing company, completed a $12 million Series B round led by Qiming Venture Partners, which also led the $6 million Series A round. Founded in 2015, Tisenc is a China-foreign JV that offers single-use point-of-care automatic chemiluminescence (CLIA) analyzers and more than 100 matching in vitro diagnostic reagents. The company says its innovative ACCRE system can serve in emergency departments, STAT laboratories and core laboratories. Tisenc will use the proceeds of the funding to advance its R&D, increase production capacity and expand global marketing. More details....

Share this with colleagues:

Original Article: Tisenc Medical Raises $12 Million for Point-of-Care Chemiluminescence Testing

NEXT ARTICLE

More From BioPortfolio on "Tisenc Medical Raises $12 Million for Point-of-Care Chemiluminescence Testing"

Quick Search